June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
HISTONE ACETYLATION AS AN EPIGENETIC REGULATOR OF GLAUCOMA-ASSOCIATED GROWTH FACTORS IN THE TRABECULAR MESHWORK
Author Affiliations & Notes
  • Jaclyn Bermudez
    Cell Biology and Immunology, University of North Texas Health Science Center, Fort Worth, TX
    North Texas Eye Research Institute, Forth Worth, TX
  • Hannah Webber
    Cell Biology and Immunology, University of North Texas Health Science Center, Fort Worth, TX
    North Texas Eye Research Institute, Forth Worth, TX
  • Abbot F Clark
    Cell Biology and Immunology, University of North Texas Health Science Center, Fort Worth, TX
    North Texas Eye Research Institute, Forth Worth, TX
  • Weiming Mao
    Cell Biology and Immunology, University of North Texas Health Science Center, Fort Worth, TX
    North Texas Eye Research Institute, Forth Worth, TX
  • Footnotes
    Commercial Relationships Jaclyn Bermudez, None; Hannah Webber, None; Abbot Clark, Genzyme-Sanofi (C), ISIS Pharmaceuticals (C), Reata Pharmaceuticals (F), Sanofi- Fovea (C); Weiming Mao, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3275. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jaclyn Bermudez, Hannah Webber, Abbot F Clark, Weiming Mao; HISTONE ACETYLATION AS AN EPIGENETIC REGULATOR OF GLAUCOMA-ASSOCIATED GROWTH FACTORS IN THE TRABECULAR MESHWORK. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3275.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Glaucoma is a leading cause of blindness in the U.S. and worldwide. This disease leads to progressive, irreversible damage to the optic nerve and visual function. The primary risk factor of primary open angle glaucoma (POAG), the major type of glaucoma, is elevated intraocular pressure (IOP). IOP elevation in glaucoma patients is due to glaucomatous insults to the trabecular meshwork (TM) and compromised TM function, which increase aqueous humor outflow resistance. In the glaucomatous TM (GTM), there is excessive extracellular matrix (ECM) protein deposition. Many studies have suggested that cell signaling pathways, such as the transforming growth factor beta (TGF-β) and Wnt signaling pathways, play key roles in TM homeostasis. The growth factors that are associated with these pathways, including TGFβ2 and sFRP1, are increased in the GTM cells compared to normal TM cells. Little is known about the role of epigenetics in regulating glaucoma-associated growth factors in the TM. We hypothesize that histone acetylation is responsible for the increased expression of glaucoma associated factors in the TM.

Methods: Primary human TM cell cultures were treated with 10nM Thailandepsin (TDP-A), a histone deacetylase inhibitor (HDACi), or 1% DMSO as vehicle control for 3 - 4 days. RNA was extracted for qPCR to compare gene expression. We also treated paired perfusion cultured bovine anterior segments with DMSO or TDP-A for 7 to 10 days. Additionally, we treated paired perfused anterior segments with TDP-A or TDP-A plus sFRP-1 or TGFβ receptor 1 inhibitors. The IOPs of the bovine eyes were continuously monitored. Data were analyzed by using Student’s t-test. P values less than 0.05 were considered significant.

Results: TDP-A elevated the expression of sFRP-1 and TGFβ2 in TM cell cultures. Our bovine eye perfusion culture study also showed that TDP-A treatment increased the expression of sFRP-1 and TGFβ2 as well as significantly elevated IOP (n=9, p<0.05). Furthermore, use of sFRP-1 or TGFβ receptor 1 inhibitors decreased IOP.

Conclusions: Histone acetylation may play an important role in the dysregulation of growth factors in the GTM. This mechanism provides a unique opportunity to elucidate the etiology of POAG. Also, TDP-A is a potent HDACi that can be used as a powerful research tool in glaucoma research.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×